About Jinbo
Located in Tai Yuan Shi, Shan Xi Sheng, Jinbo Bio-Pharmaceutical operates China’s leading cosmetic lab specializing in humanized collagen production. Since 2008, the facility has pioneered:
- Type III collagen with 1.83x higher activity than human collagen
- Biological fermentation methods for large-scale manufacturing
- 32 patents for recombinant protein engineering
- NMPA-approved medical grade products
The company’s industrial base in Jin Bo Jie represents the world’s largest humanized collagen production facility, serving pharmaceutical and cosmetic industries with non-animal origin products.
Frequently asked questions
Jinbo Bio-Pharmaceutical produces the following:
- Type III Humanized Collagen
- Triple helix structure with 164.88° flexible bending
- 100% match to human collagen functional region
- 1.83x higher activity vs human collagen
- Production Methods
- Biological fermentation processes
- Natural index = 1
- Non-animal origin materials
All products have NMPA approval for medical and cosmetic applications.
The company’s technical profile includes:
| Category | Details |
|---|---|
| Research Recognition |
|
| Production Standards |
|
| Technology Platform |
|
Jinbo Bio-Pharmaceutical operates in these areas:
- Stock Exchange Listing
- NEEQ listing since 2008
- Stock code: 832982
- Manufacturing Facilities
- Industrial-scale production base
- Operational since 2022
- International Reach
- Patent holdings in China
- International patent portfolio
- Global protein database presence
More details about Jinbo
Leading biotechnology innovation at Jinbo Bio-Pharmaceutical
Founded in 2008, Jinbo Bio-Pharmaceutical has established itself as a pioneer in biotechnology and collagen research. Located in Tai Yuan Shi, Shan Xi Sheng, China, the company achieved a significant milestone by being listed on the National Equities Exchange and Quotations.
Advanced research and development facilities
Operating as a cosmetic lab and pharmaceutical research center, Jinbo Bio-Pharmaceutical leverages its state-of-the-art facilities to develop innovative collagen-based solutions. The company’s research center in Jin Bo Jie houses specialized equipment for protein engineering and structural analysis.
Technological breakthroughs in collagen development
The company’s proprietary triple helix structure technology achieves a 164.88° flexible bending, matching human type III collagen with enhanced activity. This advancement is protected by 32 Chinese and international patents.
Production capabilities and standards
As of 2022, Jinbo Bio-Pharmaceutical operates the largest industrial base for humanized collagen products worldwide. The facility employs biological fermentation processes to ensure consistent, high-quality production.
Quality assurance and safety protocols
- Non-animal origin products
- Zero crosslinker usage
- National Medical Products Administration (NMPA) approved
- Documented in International Protein Structure Data Bank
Research and development focus
The company maintains dedicated teams for:
- Protein structure analysis
- Medical grade collagen development
- Pharmaceutical manufacturing optimization
- Biotechnology innovation
Location and market presence
Based in Tai Yuan Shi, the company’s strategic location in China’s Shan Xi Sheng region facilitates distribution across Asian markets while maintaining strong research collaborations with international institutions.
Company gallery
